Clinical Trial of Intravenous Alvespimycin in Patients With Her2 Positive Breast Cancer

NCT00780000 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Alvespimycin

Sponsor

Bristol-Myers Squibb